GlobalData全新预测,女性不育药物市场2028年将增至25亿美元

2019-10-18 不详 MedSci原创

GlobalData的最新研究预测,从2018年到2028年,全球女性不育药物市场将以3.4%的复合年增长率增长,市场将增长到25亿美元。2018年市场价值为18亿美元,这种增长将部分归因于辅助生殖技术(ART)治疗率的增长。

GlobalData的最新研究预测,从2018年到2028年,全球女性不育药物市场将以3.4%的复合年增长率增长,到2028年市场将增长到25亿美元。2018年市场价值为18亿美元,这种增长将部分归因于辅助生殖技术(ART)治疗率的增长。

研究显示三种药物在2018年占据了超过50%的市场份额:

1. EMD Serono的Gonal-F(促卵泡素α)

2. 默克的Follistim(促卵泡素β)

3. Ferring Pharmaceuticals的Menopur(促生育素)。

GlobalData的高级药物分析师Kelly Lambrinos 解释说:"越来越多的妇女将怀孕推迟,导致了生育率普遍下降,这一现象促使了在2018年至2028年之间ART的使用增加。"尽管女性不育症治疗药物很少,但据报道,ObsEva的提高试管婴儿成功率新药nolasiban是市场增长的一个主要动力。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2065944, encodeId=2ebc2065944d6, content=<a href='/topic/show?id=2c638e72964' target=_blank style='color:#2F92EE;'>#药物市场#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87729, encryptionId=2c638e72964, topicName=药物市场)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Nov 07 02:01:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466090, encodeId=eb2b14660906e, content=<a href='/topic/show?id=217c292009' target=_blank style='color:#2F92EE;'>#ATA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2920, encryptionId=217c292009, topicName=ATA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387a6772119, createdName=bbjsj_1981, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469414, encodeId=5909146941422, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2276, encryptionId=9d6522e613, topicName=ALD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f67025397, createdName=zhangjingnwpu, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2065944, encodeId=2ebc2065944d6, content=<a href='/topic/show?id=2c638e72964' target=_blank style='color:#2F92EE;'>#药物市场#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87729, encryptionId=2c638e72964, topicName=药物市场)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Nov 07 02:01:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466090, encodeId=eb2b14660906e, content=<a href='/topic/show?id=217c292009' target=_blank style='color:#2F92EE;'>#ATA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2920, encryptionId=217c292009, topicName=ATA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387a6772119, createdName=bbjsj_1981, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469414, encodeId=5909146941422, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2276, encryptionId=9d6522e613, topicName=ALD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f67025397, createdName=zhangjingnwpu, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 bbjsj_1981
  3. [GetPortalCommentsPageByObjectIdResponse(id=2065944, encodeId=2ebc2065944d6, content=<a href='/topic/show?id=2c638e72964' target=_blank style='color:#2F92EE;'>#药物市场#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87729, encryptionId=2c638e72964, topicName=药物市场)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Nov 07 02:01:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466090, encodeId=eb2b14660906e, content=<a href='/topic/show?id=217c292009' target=_blank style='color:#2F92EE;'>#ATA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2920, encryptionId=217c292009, topicName=ATA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387a6772119, createdName=bbjsj_1981, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469414, encodeId=5909146941422, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2276, encryptionId=9d6522e613, topicName=ALD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64f67025397, createdName=zhangjingnwpu, createdTime=Sun Oct 20 10:01:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 zhangjingnwpu